Inspirata Announces New Software Release and Partnership with Hamamatsu at Digital Pathology & AI Congress in London, December 6-7
Visit stand 30 at the 5th Digital Pathology and AI Congress, London to learn how Inspirata is igniting digital pathology with new software features and functions in release v2.0.8.
London, United Kingdom, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata® Europe, Ltd. today revealed it has entered into a partnership agreement with Hamamatsu Photonics affording shared customers with the ability to view native Hamamatsu .ndpi images within Inspirata’s Dynamyx™ digital pathology software. Inspirata and Hamamatsu will also be showcasing the many benefits this technical partnership will bring to clinical laboratories as part of both providers’ scheduled participation in Digital Pathology & AI Congress, London.
“By bringing on new leading scanner partners and enhancing the viewer capabilities, Dynamyx™ is positioning itself as the nucleus of a digital pathology ecosystem,” says Inspirata Founder Dr. Mark Lloyd. “We are thrilled to be seamlessly integrated with the high quality Whole Slide Images produced by the diverse line of Hamamatsu scanners, as it gives our joint clients an exemplary user experience while protecting any previous investment in scanners and allowing for the growth of new instruments.”
The Hamamatsu integration is included as part of release v2.0.8, comes just three months after Inspirata’s last major update and further exemplifies the partnership philosophy which underpins their mission and vision. “We are bringing scanners, image analysis algorithms and AP-LIS/ LIMS vendors together to create a comprehensive digital workflow which empowers pathologists to work more efficiently and effectively,” says General Manager of Inspirata Europe, Ltd. Tim Wing. “With the Royal College of Pathologists’ 2018 Histopathology Workforce Surveyi surfacing just three percent of histopathology departments in the UK possess sufficient staff to meet demand, equipping those covering the shortfall to work smarter is imperative. The pathology and laboratory community are desperately appealing for providers to work closer together for the betterment of patients and this partnership speaks to what can be achieved when they do.”
“Hamamatsu Photonics is delighted to collaborate with Inspirata and is excited that our renowned range of WSI scanners will form a key part of such an integrated digital pathology workflow solution,” explains Hamamatsu Photonics Europe Nanozoomer Product Manager Emmanuel Pirson. “We expect this partnership to contribute to an accelerated uptake of integrated digital pathology solutions within the European clinical market. Likewise, this collaboration represents just one of a number of steps our Company is taking to increase awareness and acceptance of digital pathology.”
With orders placed for a single Nanozoomer S60 and two Nanozoomer S360, one of the early beneficiaries of the Inspirata and Hamamatsu partnership will be Path Links in Lincoln. Representing one of the largest clinical pathology networks in the UK, Path Links serves a population of approximately one million and processes four and a half million specimens each year. “When undertaking a transformation as significant as migrating from analogue to digital pathology, it is essential to have the freedom as an institution to select the blend of providers which most appropriately match your requirements,” says Mick Chomyn, Path Links General Manager. “Having spent the last few months really putting them through their paces, we are confident that the Hamamatsu scanners represent an excellent fit and will serve to complement our existing scanner investments.”
Located at stand 30 at Digital Pathology & AI Congress, event attendees will be able to participate in interactive demonstrations of the Dynamyx digital pathology workflow software and explore for themselves how real-time collaboration, case-sharing, workflow algorithms and AI-based image analysis APIs functionality could be utilized to assist their laboratory reduce turnaround times. In addition, Inspirata and Hamamatsu will be participating in a joint Congress workshop in which they will spotlight their new integration on December 7th 1.45-2.30. Registration for this workshopii is now open and can be accessed via the link here.
The pressures on pathology departments are increasing. Inspirata’s advanced workflow-centric tools and ‘open’ architecture are critical enablers of digital adoption as a way to alleviate these challenges.
About Hamamatsu Photonics
Hamamatsu has a decade of real world experience in delivering sophisticated whole slide imaging (WSI) solutions across the globe. Hamamatsu’s NanoZoomer whole slide scanner series quickly transform entire histology and cytology glass slides into diagnostic-quality digital images for duplication, annotation, storage, retrieval, and image sharing. Our intuitive viewer software and patented navigation map technique enable users to scan slides in a variety of modes and share images across networks. Applications include routine and computer-aided diagnosis in laboratories, research, education, and telepathology.
About Inspirata Europe Ltd.
Inspirata® Europe Ltd. provides oncology diagnostics workflow solutions that span digital pathology; diagnostic and predictive assays; and precision medicine. It also offers cancer informatics workflows that, in combination with its Natural Language Processing (NLP) and Artificial Intelligence (AI) algorithms structures unstructured case files and clinician notes to provide key insights for oncology-specific clinical and operational activities as well as cancer reporting. Inspirata’s flagship solution is its Cancer Information Data Trust (CIDT) that generates a longitudinal view of oncology patients—from diagnosis, through treatments and therapies, to outcomes. The CIDT has extensive applications in clinical decision support, research, education, drug discovery and clinical trials enrollment. Its use will extend to physicians, patients, researchers, pharma and others. For more information, please visit www.inspirata.com or contact email@example.com.
i Royal College of Pathologists Histopathology Workforce Survey – link here
ii The workshop is only open to those registered to attend Digital Pathology & AI Congress.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Test Release - 25-05-2019 - 21108925.5.2019 15:39:00 CEST | Pressemelding
Test Sub Headline - 2067088 Chicago, May 25, 2019 (GLOBE NEWSWIRE) -- American HealthCare Lending, the leading non-recourse patient financing platform serving health systems, physician groups, surgical centers, and other healthcare providers throughout the country, today announced that it will showcase its patient financing platform at the Healthcare Financial Management Association's ANI 2014 Conference in Las Vegas June 22-25. Hosted by the nation's leading membership organization for healthcare financial management executives and leaders, HFMA's 2014 National Institute is a place for top executives and key decision makers to explore solutions to the most pressing issues facing the industry. American HealthCare Lending's patient financing solution addresses one of these key issues, the dramatic rise in out-of-pocket patient responsibility, by delivering financing options designed to fulfill the company's mission to Make Healthcare Affordable™. Attachment sample
Biome Grow Inc. to Announce First Quarter Fiscal 2019 Financial Results.24.5.2019 19:08:00 CEST | Pressemelding
TORONTO, May 24, 2019 (GLOBE NEWSWIRE) -- Biome Grow Inc. (“Biome” or the “Company”) (CSE:BIO, OTCQB: BIOIF, 6OTA:GR) will release its financial results for the first quarter ended March 31, 2019 before market open on May 29, 2019. Following the release of its first quarter 2019 financial results, Biome will host a conference call and audio webcast with Khurram Malik, CEO at 8:30am Eastern Time May 29, 2019. Webcast information A live audio webcast will be available at https://event.on24.com/wcc/r/2015980/CEAD1B37BDD7710D021A38D2B79B5C45 Calling Information Toll Free Dial-In Number: 1 (866) 211 3199 International Dial-In Number (647) 689 6601 Conference ID 8693906 About Biome Biome wholly owns five subsidiaries, including: The Back Home Medical Cannabis Corporation, a company incorporated under the laws of the Province of Newfoundland and Labrador and in the late stages of applying for a license under the Cannabis Act; Great Lakes Cannabis, a company incorporated under the laws of the
Jason Lamb of Gates Foundation Named New Chair of CGAP’s Executive Committee24.5.2019 17:04:00 CEST | Pressemelding
CGAP CEO calls for renewed focus on retail credit to support growth and jobs for the poor Beirut, Lebanon, May 24, 2019 (GLOBE NEWSWIRE) -- Jason Lamb from the Bill & Melinda Gates Foundation, was elected chair of the Executive Committee for The Consultative Group to Assist the Poor (CGAP) at its annual meeting on Wednesday. Lamb will succeed Carolina Trivelli, senior researcher at the Instituto de Estudios Peruanos and Peru’s former Minister of Development and Social Inclusion. Under Trivelli’s leadership CGAP adopted its new five-year strategy and theory of change that places empowering the poor through financial services to capture opportunities and build resilience at the heart of CGAP’s work. At the Gates Foundation, Lamb is Deputy Director, Financial Services for the Poor (FSP) and manages focus country implementation in Bangladesh, Pakistan, Indonesia, Nigeria, Tanzania, Kenya and Uganda. He has served on CGAP’s Executive Committee, which functions like a board of directors prov
Gainsight Unveils the Customer Cloud, the Future of Customer Success Technology23.5.2019 19:30:00 CEST | Pressemelding
New Products Announced at Pulse 2019 to Drive Customer Success Across the Enterprise SAN FRANCISCO, May 23, 2019 (GLOBE NEWSWIRE) -- Today, Gainsight® launched the Customer Cloud —a first-of-its-kind solution for subscription businesses looking to adopt a customer-centric philosophy that enables them to retain customers while also driving company growth post-sale. According to the 2018 Subscription Economy Index report, subscription companies are growing five times faster than S&P and retail sales. The Gainsight Customer Cloud caters to these businesses by combining the company’s Customer Success and Product Experience products with three new product innovations to offer a powerful set of solutions for businesses to optimize their subscription strategies through technology. “With the maturity of cloud technology and the subscription economy, customer expectations have drastically changed. Companies are struggling to leverage existing tools to satisfy the increasing demands of their cus
Lowered Return Expectations Among Several Trends Pointing to a Shift in Private Markets Due Diligence says New eVestment Survey23.5.2019 15:30:00 CEST | Pressemelding
ATLANTA, May 23, 2019 (GLOBE NEWSWIRE) -- Private markets funds have continued to rake in new commitments from institutional investors eager to diversify their portfolios and capture the returns private markets investments can offer. However, investors are now tempering their private markets return expectations. Coupled with other industry trends, this will have implications for private markets fundraising and due diligence according to a new eVestment report, produced in association with parent company Nasdaq. The 2019 eVestment Private Markets Due Diligence Survey of institutional investors, consultants and private markets fund managers finds that 52% of investors expect returns in the space to decline in the future (page 16). Only 12% of investors expected private equity returns to increase, with the balance – 36% – expecting returns to stay about the same. Forty-seven percent of investors surveyed expect to see lower returns in venture capital vs. just 16% of investors who expect r
Collibra Announces 2019 Excellence Awards Winners23.5.2019 15:00:00 CEST | Pressemelding
American Express, Deloitte, and Lloyds Banking Group recognized as leaders in harnessing data to drive digital transformation NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Collibra, the leader in enterprise data governance and catalog software, today announced the winners of the 2019 Collibra Excellence Awards. Presented at the annual Data Citizens conference in New York, the awards honor teams and individuals driving innovative data strategy by collaborating with Collibra. “In today’s market, organizations that are able to maximize data have the power to transform entire industries,” said Felix Van de Maele, co-founder and CEO of Collibra. “We’re proud to honor the recipients of the Collibra Excellence Awards, a cutting-edge group at the forefront of data-driven innovation.” The 2019 Collibra Excellence Award Winners: American Express — Distinguished Data Program of the Year American Express was recognized for its data governance transformation, which began as a compliance initiative and